Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?

This publication has 33 references indexed in Scilit:

• The role of blood glucose‐lowering drugs in the light of the UKPDS
  Diabetes, Obesity and Metabolism, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications
  Diabetic Medicine, 1998
• Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition
  Diabetes Care, 1998
• Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
  Diabetes Care, 1998
• The United Kingdom Prospective Diabetes Study (UKPDS) Implications for the Pharmacotherapy of Type 2 Diabetes Mellitus
  Experimental and Clinical Endocrinology & Diabetes, 1998
• Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs
  British Journal of Pharmacology, 1997
• Stimulation of Insulin Release by Non-Sulfonylurea Hypoglycemic Agents: The Meglitinide Family
  Hormone and Metabolic Research, 1995
• Impaired Glucose Tolerance and its Relationship to ECG-Indicated Coronary Heart Disease and Risk Factors Among Chinese: Da Qing IGT and diabetes study
  Diabetes Care, 1993
• Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1988